Acquiring Motilium: tips for the generic option - in the UK

Survey of the high pointic

Active compound: domperidone (often marketed as Motilium).

Primary role: a medicine used to relieve nausea and vomiting and to promote stomach and upper gut motility when clinically appropriate.

Common presentation in the UK: 10 mg oral tablets are widely supplied. Liquid forms exist but can be less widely obtainable.

Mechanism: domperidone blocks peripheral dopamine D2/D3 receptors and acts mainly outside the central nervous system to speed gastric emptying and coordinate contractions in the upper gut. It penetrates the brain less than many antiemetics, so central nervous system effects are less frequent, but there are important cardiac safety implications to evaluate. See Safety and Absolute notes on when to avoid this treatment and Drug Interaction Studies see the attached details for more information disclosed.

This page has quick links: dosing, markers, uK price framework, and status of lawful authorization and purchasing advice.

Cues and Endorsed Utilizations

In the UK domperidone is primarily a short-term prescription option for treating nausea and vomiting. Use for delayed gastric emptying or to improve upper gut motility should be based on clinical judgement and licensing guidance and counsel.

• Short-term treatment of acute nausea and vomiting when prescribed by a healthcare professional.
• To enhance upper gastrointestinal motility in selected patients where this is likely to help symptoms.
• As an adjunct under specialist supervision in situations such as limiting nausea from certain chemotherapy regimens.
• In specific procedural or diagnostic settings where increased gastric motility is requested by a specialist.

Do not alter dose or stop treatment without consulting the prescriber. For separate guidance on adults and children, consult the the dosing details section.

Techniques for Taking Domperidone

Always follow instructions from your prescriber or pharmacist. Tablets are usually swallowed with water and taken before meals to enhance the prokinetic effect.

Adults and Adolescents (12 years and older, over 35 kg)

• Usual regimen: 10 mg up to three times daily, often taken 15 to 30 minutes before food.
• Maximum recommended total daily dose: 30 mg.
• For acute nausea, treatment is commonly limited to short courses (for example up to 7 days) unless otherwise directed by the prescriber.

The infant and child population and Younger Patients

Domperidone is not routinely advised for children under 12 years or under 35 kg except under specialist direction. Adult tablets are not suitable for small children without appropriate a different solution formulations and dosing instructions.

Renal and Hepatic Considerations

• Moderate to severe liver impairment: domperidone is contraindicated.
• Severe kidney impairment: elimination may be slower; clinicians may reduce dose or dosing frequency and should review ongoing need.

Dose not taken this time

If a dose is forgotten, take it immediately after you remember, unless the next dose is near. Do not double up to compensate for a i skipped the dose.

Excipients and Lactose

Some domperidone products include lactose. If you have lactose intolerance, hereditary galactosaemia, or glucose-galactose malabsorption, ask a pharmacist for a suitable a different possibility.

Ahead of starting treatmentplease audit this. cardiac cautions and discuss concomitant medicines that might interact. See Safety Rules and Exclusion criteria for therapy and Drug Interaction Risks and Safety.

Safety Notices and Conditions where use is not advised

Do not take domperidone if any of the following apply:

• You have or are suspected to have a prolonged QT interval, serious ventricular arrhythmias or significant structural heart disease.
• You have moderate or severe hepatic impairment.
• You are allergic to domperidone or any other ingredient in the product.
• You are taking medicines known to markedly prolong the QT interval or strong CYP3A4 inhibitors (see Drug Interaction Checks).
• There is active gastrointestinal bleeding, perforation or obstruction where increasing motility could be harmful.
• You have a prolactin-secreting pituitary tumour (prolactinoma).

Use caution if you have electrolyte disturbances (low potassium or magnesium), bradycardia, significant renal impairment or other risk factors for abnormal heart rhythms. Seek urgent medical help if you develop palpitations, fainting or sudden severe dizziness while taking domperidone.

If in doubtcase review your medical history and all medicines with a pharmacist or prescriber before initiating treatment.

Communication with the addition of the interaction between participants Among Drugs

Certain medicines can raise domperidone concentrations and increase cardiac risk; others may lessen its motility effects. Always tell healthcare professionals about all prescription and over-the-counter medicines, vitamins and herbal supplements you use.

Medicines That Increase Domperidone Exposure or Cardiac Risk

• Strong inhibitors of CYP3A4 such as some azole antifungals (for example ketoconazole, itraconazole), certain macrolide antibiotics (for example erythromycin, clarithromycin), some HIV protease inhibitors, and some calcium channel blockers like verapamil and diltiazem.
• Other drugs that prolong the QT interval, including some antiarrhythmics, antipsychotics and certain antidepressants.

Medicines That May Reduce the Effect

• Opioids (for example morphine or codeine) that slow gastrointestinal motility.
• Antimuscarinic agents such as hyoscine, oxybutynin or tolterodine which can counteract prokinetic effects.

Additional items may exist beyond this list. Review the status product information or speak to a pharmacist before starting or stopping any medicine. For related health risks that preclude therapy see Safety Aspects and Contraevidence to use in these settings.

Prenatal and lactation resources

Safety data in pregnancy are limited. Domperidone should only be used during pregnancy if the potential benefit justifies any possible risk, after discussion with a clinician.

Small amounts of domperidone may appear in breast milk. Routine use for maternal nausea while breastfeeding is not usually recommended unless a prescriber judges it necessary. Using domperidone solely to increase milk production is not routinely recommended in the UK because of possible cardiac risks; specialist supervision is advised if considered.

Inform your prescriber if you are pregnant, planning pregnancy or breastfeeding. Report any cardiac symptoms promptly if treatment is started.

Potential lingering effects

Many people tolerate domperidone without problems. When unintended consequences occur they are frequently mild and settle after stopping the medicine. Seek immediate help if you notice symptoms suggestive of a dangerous heart rhythm, such as fainting, sudden severe dizziness or palpitations.

Common and Less Serious Reactions

• My mouth is dry, chronic head pain, abdominal cramps and diarrhoea.
• Raised prolactin may cause breast changes, unexpected milk production or menstrual disturbances.

Uncommon and Rare Reactions

• Allergic reactions such as skin rash or hives.
• Reduced libido, more often reported in men.
• Extrapyramidal symptoms including tremor, muscle stiffness or involuntary movements; these need urgent assessment.

If you are worried about any symptoms, contact a healthcare professional. In the UK, suspected adverse reactions can be reported to the Yellow Card scheme to support safety constant monitoring.

Safe Storage media Guidelines

• Keep the medicine in its original packaging to protect it from moisture and light.
• Store at 20 to 25 C (68 to 77 F) unless the leaflet states otherwise.
• Keep out of sight and reach of children and pets and avoid storing in bathrooms.
• Check expiry dates and return unused or out-of-date medicines to a pharmacy for safe disposal.

Auxiliary medicines and related treatments

Choice of antiemetic or prokinetic depends on the cause of nausea, comorbidities, age and high potential two-way communication in actions across departments improve alignment.. Options commonly considered include:

• Ondansetron: a 5-HT3 antagonist commonly used for chemotherapy- or surgery-related nausea; constipation and, in some cases, QT effects can occur.
• Metoclopramide: has antiemetic and prokinetic effects but crosses into the brain more readily, raising the risk of drowsiness and extrapyramidal effects; usually for short-term use.
• Cyclizine: useful for motion sickness and some postoperative nausea; sedation is common.
• Prochlorperazine: used for migraine-related or vestibular nausea; may cause drowsiness and occasionally dystonic reactions.
• Low-dose erythromycin (off-label for motility): acts on motilin receptors but can cause cramps and interacts with other drugs.
• Non-drug approaches such as dietary changes, ginger supplements and staying hydrated may relieve mild nausea.

Discuss the best choice for you with a prescriber or pharmacist. For a brief price comparison chart see Approximate UK Prices.

Approximate UK Prices

Private billing rates is not uniform and depends on pharmacy, brand, and pack size. NHS prescription arrangements differ across the UK and may affect cost.

• Generic domperidone 10 mg, 30 tablets: roughly 4 to 9 GBP; a branded product such as Motilium, if available privately, might be around 10 to 15 GBP.
• Ondansetron (4 mg or 8 mg), small packs: around 8 to 20 GBP depending on strength and brand.
• Metoclopramide 10 mg, 28 tablets: commonly 2 to 6 GBP.
• Prochlorperazine buccal 3 mg, small packs: approximately 7 to 12 GBP in private sales.
• Cyclizine 50 mg, larger packs: typically 5 to 12 GBP privately.

NHS prescription charges in England are a fixed fee per item (check the current NHS rate). Prescriptions are free in Scotland, Wales and Northern Ireland. Private online consultations or postal services may add consultation or delivery fees, often in the 10 to 30 GBP range.

UK Legal Eligibility and Buying Rules

• Domperidone is a Prescription Only Medicine (POM) in the UK and cannot legally be supplied without a valid prescription.
• Licensed use commonly covers short-term relief of nausea and vomiting with adult dosing up to 10 mg three times daily for short courses; national guidance highlights cardiac cautions and risks due to interactive engagement (see Safety Standards and Reasons to avoid use and Drug-Drug Communication and interactive engagement).
• When buying online, use pharmacies registered with the General Pharmaceutical Council (GPhC) and verify credentials on the GPhC register. Avoid unregulated websites or overseas suppliers who do not require proper prescriptions.
• Importing prescription medicines for personal use without correct documentation may breach MHRA rules. Check MHRA guidance before attempting to bring medication into the UK.
• Driving and using machinery: domperidone is not usually sedating, but if you feel unwell or dizzy do not drive or operate machinery.
• Report suspected harmful bodily effects via the Yellow Card scheme to contribute to national pharmacovigilance.

For the latest regulatory advice consult MHRA, NHS resources or speak to a pharmacist.